The current scenario of medical treatment is centered on the paradigm “one size fits all” where most patients receive the same drugs at the same doses and frequencies as others. But this does not hold up in all treatments especially for pediatric treatment. Children often need the same medication as adults but in much lower doses and it is difficult to accurately divide existing adult medicines into smaller doses. We in TNO along with Erasmus Medical Centrum (well-known hospital in Netherlands) are working on a solution for this problem using the 3D printing technology. The advantage of using 3D printing is that it can print the prescribed dose for a child very precisely. With success in this test case, we envision that in future 3D printing will be able to accelerate the development of personalized medication and fulfill the unmet needs in both pediatric and geriatric population.
Learning Objectives:
Upon completion, participant will have more insight in the limitations of conventional pediatric dosing & be challenged to identify the possibilities and advantages of implementing 3D printing technology in healthcare domain.
Upon completion, participant will discuss and understand in details ethical considerations and regulatory aspects associated with personalized dosing and 3D printing in pediatric medicine.
Upon completion, participant will construct a comprehensive plan for raising awareness and promoting acceptance of personalized pediatric dosing strategies among healthcare stakeholders and the public.
Upon completion, participant will apply the knowledge gained to develop strategies for optimizing drug formulations and dosages tailored to pediatric patients.
Upon completion, participant will illustrate the potential future advancements and trends in personalized pediatric dosing and 3D printing within the medical field.